- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat ; volume:20 ; number:1 ; day:6 ; month:9 ; year:2019 ; pages:1-9 ; date:12.2019
Respiratory research ; 20, Heft 1 (6.9.2019), 1-9, 12.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-019-1161-4
- URN
-
urn:nbn:de:101:1-2020012320562112112436
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maher, Toby M.
- Strek, Mary E.
- SpringerLink (Online service)
Other Objects (12)
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Idiopathic pulmonary fibrosis: moving forward
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Oncogenic signaling in idiopathic pulmonary fibrosis
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Idiopathic pulmonary fibrosis: moving forward
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Oncogenic signaling in idiopathic pulmonary fibrosis
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Idiopathic pulmonary fibrosis: moving forward
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis